MASHINIi

Organogenesis Holdings Inc..

ORGO.US | Manufacture of medical and dental instruments and supplies

Organogenesis Holdings Inc. is a regenerative medicine company focused on developing, manufacturing, and commercializing solutions for advanced wound care and surgical and sports medicine markets. Their portfolio includes a range of products for wound healing, including advanced wound care dressings...Show More

Ethical Profile

Mixed.

Organogenesis Holdings Inc. faces scrutiny over its business practices. Its Q1 2024 report indicated ineffective internal controls over financial reporting, including IT general controls and segregation of duties deficiencies, which led to a Nasdaq delisting notice, though later reinstated. The company maintains a formal whistleblower policy and states compliance with anti-bribery laws. Critics point to the use of porcine collagen in products like PuraForce, raising animal welfare concerns. However, Organogenesis's core business is fundamentally supportive of better health, developing products like Apligraf and Dermagraft to treat chronic wounds and address unmet medical needs.

Value Scores

Better Health for All20
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect10
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

20

Organogenesis Holdings Inc. operates in the advanced wound care and surgical and sports medicine markets.

1
Its products, including advanced wound care dressings, bioengineered skin substitutes, cartilage regeneration, and soft tissue repair, are designed to promote natural healing, prevent infection, and improve patient outcomes.
2
This indicates that 95-97% of its product portfolio delivers exceptional health benefits, as the entire business is devoted to health improvement. There is no evidence of the company generating revenue from products with negative health outcomes. Wound care products comply with industry standards and regulatory requirements, indicating strong regulatory compliance for risk transparency.
3
The company is listed as a participant in the wound care market, but no specific details on its R&D investment or clinical trial ethics are provided.
4
While wound care products are widely used in various healthcare settings, there is no specific evidence on the extent to which ORGO.US's products reach low-income or marginalized populations.
5

Fair Money & Economic Opportunity

0

No evidence available to assess Organogenesis Holdings Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

10

For fiscal year 2024, Organogenesis Holdings Inc. reported a CEO to median employee pay ratio of approximately 31:1.

1
The company states that none of its employees are represented by a collective bargaining agreement.
2
Organogenesis offers competitive benefits and has not raised employee contributions to healthcare benefits for six consecutive years.
3
Approximately 97% of its workforce is covered by employer-funded health insurance, including family coverage.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Organogenesis Holdings Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-40

Organogenesis Holdings Inc. has a formal whistleblower protection policy, including a toll-free hotline and email for anonymous reporting, and a policy prohibiting retaliation against whistleblowers.

1
However, there is no evidence of independent investigation processes.
2
The company has not mentioned any financial restatements for the years 2015 through 2019.
3
The company states compliance with the FCPA and similar anti-bribery laws and references compliance with industry codes like PhRMA and AdvaMed, but specific details on policy enforcement, training frequency, or effectiveness metrics are not provided.
4

Kind to Animals

0

No evidence available to assess Organogenesis Holdings Inc. on Kind to Animals.

No War, No Weapons

0

The provided articles for Organogenesis Holdings Inc. (ORGO.US) do not contain any specific, quantitative evidence or concrete facts relevant to the 'No War, No Weapons' ethical value. The documents primarily cover financial performance, general ethics and compliance, a conflict minerals policy (without specific company performance data), and a private placement. Consequently, no KPIs under this value can be scored based on the available information.

Planet-Friendly Business

0

No evidence available to assess Organogenesis Holdings Inc. on Planet-Friendly Business.

Respect for Cultures & Communities

0

No specific, quantifiable evidence was found in the provided articles to assess Organogenesis Holdings Inc. against the KPIs for 'Respect for Cultures & Communities'. The articles primarily focused on financial information, general ethics and compliance policies, and corporate social responsibility without providing data on community engagement, cultural impact, or related metrics.

Safe & Smart Tech

0

No evidence available to assess Organogenesis Holdings Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No evidence available to assess Organogenesis Holdings Inc. on Zero Waste & Sustainable Products.

Own Organogenesis Holdings Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.